Chantix Label Updated To Warn Of Suicide Risk
Pfizer, who make the smoking cessation drug Chantix (varenicline), have updated the drug’s labelling in the United States to reflect the fact patients may experience “serious neuropsychiatric symptoms”, including suicidal behaviour.Chantix was approved by the US Food and Drug Administration (FDA) in May 2006 as a prescription drug to help smokers quit.
More: continued here